https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Fri, 28 Jan 2022 09:18:40 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/ahh9ydfy7l0-improving-patient-access-to-cell-therapies/ Fri, 30 Apr 2021 10:09:53 +0000 http://13.40.107.223/video/ahh9ydfy7l0-improving-patient-access-to-cell-therapies/ Emanuele Ostuni, Head of Europe, Cell and Gene Therapy, Novartis Oncology, East Hanover, NJ, discusses the progress that needs to be made in improving patient access to cell therapies and highlights the importance of ensuring that therapies are aimed at the patient population for which they are approved in order to maximize potential benefit. He also describes a number of logistical challenges that manufacturers have already faced and calls for the industry to work together more closely to improve the development pathway for future therapies. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.

]]> https://mirror.vjregenmed.com/video/z4ntsleaxzs-improving-education-in-cell-therapy/ Fri, 30 Apr 2021 10:09:52 +0000 http://13.40.107.223/video/z4ntsleaxzs-improving-education-in-cell-therapy/ Emanuele Ostuni, Head of Europe, Cell and Gene Therapy, Novartis Oncology, East Hanover, NJ, discusses the importance of educating patients on novel therapeutic modalities being developed for hematological malignancies such as lymphoma, myeloma and leukemia in order to give patients a better understanding of their treatment options. He also points out that improved education for healthcare professionals on novel treatment options such as CAR-T therapy is needed in order for them to be able to make more informed decisions for their patients. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.

]]>